Illness	Number of cases
Malignant neoplasm of breast (C50.9)	387
Malignant neoplasm of breast (C50.4)	285
Carcinoma in situ of breast (D05.1)	103
Malignant neoplasm of breast (C50.2)	90
Benign neoplasm of breast (D24)	74
Malignant neoplasm of breast (C50.5)	71
Malignant neoplasm of breast (C50.3)	37
Hypertrophy of breast (N62)	32
Other disorders of breast (N64.8)	32
Malignant neoplasm of breast (C50.1)	27

Top 10 treatments

Treatment	Number
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer (3-760)	378
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.13)	350
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a0)	343
Complex differential diagnostic sonography of soft tissue tumours with quantitative measurement (3-036)	288
Revision operations (5-983)	218
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.12)	190
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a1)	185
Treatment procedures requiring dyes (5-989)	185
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.90)	150
Surgical removal of the breast (mastectomy), without taking the axillary lymph nodes (5-872.1)	147

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
147	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
96	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
96	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)